An alternative approach for daily perineal care of patients with indwelling urinary catheterization: Photodynamic inactivation with cationic porphyrin derivatives
DOI:
https://doi.org/10.14687/jhs.v20i3.6395Keywords:
Indwelling urinary catheterization, catheter-associated urinary tract infections, daily perineal care, antiseptic, antimicrobial photodynamic inactivation, MDR, E.coli, K. pneumoniae, MRSA, C. albicansAbstract
Background: Catheter-associated urinary tract infections (CAUTI) constitute a significant portion of healthcare-associated infections. Using antiseptic for routine daily perineal care of patients with IUC may reduce CAUTIs.
Aim: This study aimed to examine antimicrobial photodynamic inactivation (aPDI) against clinical isolates for use in the daily perineal care of patients with IUC. In addition, it was also aimed to compare the antimicrobial activities of aPDI and 0.1% chlorhexidine gluconate.
Methods: In this in-vitro study, cationic porphyrin derivatives (CPDs) were used as photosensitizers in the experiments. CPDs, named PM, PE, PN, and PL were synthesized by the researchers. A diode laser device emitting light with a wavelength of 450 nm (blue light) was used as the light source. Methicillin-resistant Staphylococcus aureus (MRSA), Escherichia coli and Klebsiella pneumoniae with multidrug-resistant (MDR) properties and Candida albicans were used. Photosensitizer (PS), aPDI, light (L), and control (C) groups in aPDI experiments; control (C) and chlorhexidine gluconate 0.1% groups were used in the chlorhexidine gluconate experiments. Survival was calculated based on CFU/mL in the control group.
Results: In experiments, combinations of 25 J/cm² with 6.25 and 3.125 µM PM, PE reduced E. coli, K. pneumoniae, MRSA, and C. albicans survival in the range of 8.70 to 11.53 log₁₀. In aPDI experiments performed with 6.25 and 3.125 µM PN and PL concentrations at the same energy density, reductions in the range of 4.41 to 0.17 log₁₀ were observed in all four clinical isolates. In experiments where 1.5625 µM concentration was used, survival decreased in the range of 8.29 to 10.87 log₁₀ in PM and PE, while antimicrobial activity was limited in PN and PL. In the 0.1% chlorhexidine gluconate experiments, the survival reduction in all four clinical isolates ranged from 8.87 to 10.24 log₁₀.
Conclusion: For PM and PE, a very strong aPDI was obtained in C. albicans, E.coli, K. pneumoniae, and MRSA at low concentrations and energy density. The same antimicrobial activity was found in experiments using 0.1% chlorhexidine gluconate. In this context, we would like to inform you that aPDI to be performed with a combination of 25 J/cm² at 6.25 and 3.125 µM concentrations of PM and PE has the potential to be an antiseptic in the daily perineal care of patients with IUC.
Downloads
Metrics
References
Bugeja S, Mistry K, Yim IHW, Tamimi A, Roberts N, Mundy AR. A new urethral catheterisation device (UCD) to manage difficult urethral catheterisation. World J Urol. 2019;37(4):595–600. Available from: https://doi.org/10.1007/s00345-018-2499-9
Kurukız S, Özden D. Distile su ve klorheksidin glukonat (%0.1) Solüsyonu ile yapılan perine bakımının kateter ilişkili idrar yolu enfeksiyonu gelişimine etkisi. DEUHFD. 2017;10(4):208–215.
Gray J, Rachakonda A, Karnon J. Pragmatic review of interventions to prevent catheter-associated urinary tract infections (CAUTIs) in adult inpatients. J Hosp Infect. 2023;136:55–74. Available from: https://doi.org/10.1016/j.jhin.2023.03.020
Jeffery N, Mundy A. Innovations in indwelling urethral catheterisation. BJU Int. 2020;125(5):664–668.
Murphy C. Innovating urinary catheter design: An introduction to the engineering challenge. Proc Inst Mech Eng Part H J Eng Med. 2019;233(1):48–57.
Dorothy RL, Blanche B, Charlotte CP, Vernon CR, Emma CS, Mabel T, et al. Guideline for prevention of catheterassociated urinary tract infections 2009. Guidel Prev Catheter Urin Tract Infect 2009. 2019;1–60. Available from: https://www.cdc.gov/infectioncontrol/pdf/guidelines/cauti-guidelines-H.pdf
Feneley, R. C., Kunin, C. M., Stickler DJ. An indwelling urinary catheter for the 21st century. BJU Int. 2012;109(12):1746–1749.
Dellimore KH, Helyer AR, Franklin SE. A scoping review of important urinary catheter induced complications. J Mater Sci Mater Med. 2013;24(8):1825–1835.
CDC. Catheter-Associated Urinary Tract Infections. Antibiot Resist Patient Saf Portal. 2021;24(7). Available from: https://arpsp.cdc.gov/profile/infections/cauti?redirect=true
Hekimoğlu CH, Şahan S. Üriner kateter ilişkili üriner sistem enfeksiyonlarında ölüm ile ilişkili faktörlerin incelenmesi. Turk Hij Den Biyol Derg. 2020;77(3):325–332.
Hekimoğlu H, Batır E, Yıldırım Gözel E, Dilek A. Ulusal Sağlik Hizmeti İlişkili Enfeksiyonlar Sürveyans Ağı (USHİESA) 2020. Hekimoğlu H, editor. T.C. Sağlik Bakanliği Halk Sağlığı Genel Müdürlüğü Bulaşıcı Hastalıklar ve Erken Uyarı Dairesi Başkanlığı. Ankarar; 2021. 10–15 p.
Keskin BH, Çalışkan E, Kaya S, Köse E, Şahin İ. Bacteria that cause urinary system infections and antibiotic resistance rates. Türk Mikrobiyoloji Cemiy Derg. 2021;51(3):254-262.
Almeida VF de, Quiliici MCB, Sabino SS, Resende DS, Rossi I, Campos PA de, et al. Appraising epidemiology data and antimicrobial resistance of urinary tract infections in critically ill adult patients: a 7-year retrospective study in a referral Brazilian hospital. Sao Paulo Med J. 2023;141(6):1–8.
Tambyah PA, Halvorson KT, Maki DG. A prospective study of pathogenesis of catheter-associated urinary tract infections. Mayo Clin Proc. 1999;74(2):131–136. Available from: http://dx.doi.org/10.4065/74.2.131
Fasugba O, Cheng AC, Gregory V, Graves N, Koerner J, Collignon P, et al. Chlorhexidine for meatal cleaning in reducing catheter-associated urinary tract infections: a multicentre stepped-wedge randomised controlled trial. Lancet Infect Dis. 2019;19(6):611–619. Available from: http://dx.doi.org/10.1016/S1473-3099(18)30736-9
Akpınar B., Yurttaş A, Karahisar F. Üriner kateterizasyona bağlı enfeksiyonun önlenmesinde hemşirenin rolü. UİBD. 2004;1(1):1–8.
Conner BT, Kelechi TJ, Nemeth LS, Mueller M, Edlund BJ, Krein SL. Exploring factors associated with nurses’ adoption of an evidence-based practice to reduce duration of catheterization. J Nurs Care Qual. 2013;28(4):319–326.
Tsuchida T, Makimoto K, Ohsako S, Fujino M, Kaneda M, Miyazaki T, et al. Relationship between catheter care and catheter-associated urinary tract infection at Japanese general hospitals: A prospective observational study. Int J Nurs Stud. 2008;45(3):352–361.
NICE. Guidance Healthcare-associated infections: prevention and control in primary and community care. NICE Natl Insititute Heal Care Excell. 2017;(March 2012):1–35. Available from: https://www.nice.org.uk/guidance/cg139/chapter/1-guidance#vascular-access-devices
Cheung K, Leung P, Wong Y ching, To O king, Yeung Y fong, Chan M wa, et al. Water versus antiseptic periurethral cleansing before catheterization among home care patients: A randomized controlled trial. Am J Infect Control. 2008;36(5):375–80.
Koskeroglu N, Durmaz G, Bahar M, Kural M, Yelken B. The role of meatal disinfection in preventing catheter-related bacteriuria in an intensive care unit: A pilot study in Turkey. J Hosp Infect. 2004;56(3):236–268.
Webster J, Hood RH, Burridge CA, Doidge ML, Phillips KM, George N. Water or antiseptic for periurethral cleaning before uninary catheterization: A randomized controlled trial. Am J Infect Control. 2001;29(6):389–394.
Mastanaiah N, Johnson JA, Roy S. Effect of dielectric and liquid on plasma sterilization using dielectric barrier discharge plasma. PLoS One. 2013;8(8):e70840. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3737149&tool=pmcentrez&rendertype=abstract
Clark M, Wright M-D. Antisepsis for urinary catheter insertion: a review of clinical effectiveness and guidelines. antisepsis urin catheter inser a rev clin eff guidel. 2019;1:1–18. Available from: https://www.cadth.ca/sites/default/files/pdf/htis/2019/RC1051 Antisepsis for Urinary Catheter Insertion Final.pdf
Taslı H, Akbıyık A, Topaloğlu N, Alptüzün V, Parlar S. Photodynamic antimicrobial activity of new porphyrin derivatives against methicillin resistant Staphylococcus aureus. J Microbiol. 2018;56(11):828–837.
Tasli H, Akbiyik A, Alptuzun V, Parlar S. Antibacterial activity of porphyrin derivatives against multidrug-resistant bacteria. Pak J Pharm Sci. 2019;32(5):2369–2373.
Akbiyik A, Taşli H, Topaloğlu N, Alptüzün V, Parlar S, Kaya S. The antibacterial activity of photodynamic agents against multidrug resistant bacteria causing wound infection. Photodiagnosis Photodyn Ther. 2022;40. 103066. https://doi.org/10.1016/j.pdpdt.2022.103066
Almeida J, Tomé JPC, Neves MGPMS, Tomé AC, Cavaleiro J a S, Cunha Â, et al. Photodynamic inactivation of multidrug-resistant bacteria in hospital wastewaters: Influence of residual antibiotics. Photochem Photobiol Sci. 2014;13(4):626–633. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24519439
Darabpour E, Kashef N, Mashayekhan S. Chitosan nanoparticles enhance the efficiency of methylene blue-mediated antimicrobial photodynamic inactivation of bacterial biofilms: An in vitro study. Photodiagnosis Photodyn Ther. 2016;14:211–217. Available from: http://dx.doi.org/10.1016/j.pdpdt.2016.04.009
Topaloglu N, Gulsoy M, Yuksel S. Antimicrobial Photodynamic therapy of resistant bacterial strains by indocyanine green and 809-nm diode laser. Photomed Laser Surg. 2013;31(4):155–162. Available from: http://online.liebertpub.com/doi/abs/10.1089/pho.2012.3430
Li Y, Zhang J, Xu Y, Han Y, Jiang B, Huang L, et al. The histopathological investigation of red and blue light emitting diode on treating skin wounds in Japanese big-ear white rabbit. PLoS One. 2016;11(6):1–11.
Mardani M, Kamrani O. Effectiveness of antimicrobial photodynamic therapy with indocyanine green against the standard and fluconazole-resistant Candida albicans. Lasers Med Sci. 2021;36(9):1971–1719. Available from: https://doi.org/10.1007/s10103-021-03389-9
Huang K, Liang J, Mo T, Zhou Y, Ying Y. Does periurethral cleaning with water prior to indwelling urinary catheterization increase the risk of urinary tract infections? A systematic review and meta-analysis. Am J Infect Control. 2018;46(12):1400–1405. Available from: https://doi.org/10.1016/j.ajic.2018.02.031
Cao Y, Gong Z, Shan J, Gao Y. Comparison of the preventive effect of urethral cleaning versus disinfection for catheter-associated urinary tract infections in adults: A network meta-analysis. Int J Infect Dis. 2018;76:102–108. Available from: https://doi.org/10.1016/j.ijid.2018.09.008
Liu JX, Werner J, Kirsch T, Zuckerman JD, Virk MS. Cytotoxicity evaluation of chlorhexidine gluconate on human fibroblasts, myoblasts, and osteoblasts. J Bone Jt Infect. 2018;3(4):165–172.
Bayraktar G, Yılmaz Göler AM, Öztürk Özener H. Klorheksidinin insan diş eti fibroblast hücre canlılığı ve sitotoksisitesi üzerindeki etkilerinin in vitro değerlendirilmesi. Eur J Res Dent. 2023;7(1):27–32.
Yayli NA, Tunc SK, Degirmenci, B. U., Dikilitas A, Taspinar M. Comparative evaluation of the cytotoxic effects of different oral antiseptics: A primary culture study. Niger J Clin Pract. 2019;22(2):1070–1077.
Ortega-Llamas L, Quiñones-Vico MI, García-Valdivia M, Fernández-González A, Ubago-Rodríguez A, Sanabria-De la Torre R, et al. Cytotoxicity and Wound Closure Evaluation in Skin Cell Lines after Treatment with Common Antiseptics for Clinical Use. Cells. 2022;11(9):1-18.
Li YC, Kuan YH, Lee TH, Huang FM, Chang YC. Assessment of the cytotoxicity of chlorhexidine by employing an in vitro mammalian test system. J Dent Sci. 2014;9(2):130–135. Available from: http://dx.doi.org/10.1016/j.jds.2013.02.011
Dosselli R, Ruiz-González R, Moret F, Agnolon V, Compagnin C, Mognato M, et al. Synthesis, Spectroscopic, and Photophysical Characterization and Photosensitizing Activity toward Prokaryotic and Eukaryotic Cells of Porphyrin-Magainin and -Buforin Conjugates. J Med Chem. 2014;57(4):1403–1415. Available from:
http://dx.doi.org/10.1021/jm401653r%5Cnfiles/902/Dosselli ?. - 2014 - Synthesis, Spectroscopic, and Photophysical Charac.pdf%5Cnfiles/903/jm401653r.html
Tomé JPC, Neves MGPMS, Tomé AC, Cavaleiro J a S, Soncin M, Magaraggia M, et al. Synthesis and antibacterial activity of new poly-S-lysine-porphyrin conjugates. J Med Chem. 2004;47(26):6649–6652.
Fila G, Kasimova K, Arenas Y, Nakonieczna J, Grinholc M, Bielawski KP, et al. Murine Model Imitating Chronic Wound Infections for Evaluation of Antimicrobial Photodynamic Therapy Efficacy. Front Microbiol. 2016;7(August):1–11. Available from: http://journal.frontiersin.org/article/10.3389/fmicb.2016.01258
Nitzan Y, Ashkenazi H. Photoinactivation of Acinetobacter baumannii and Escherichia coli B by a cationic hydrophilic porphyrin at various light wavelengths. Curr Microbiol. 2001;42(6):408–414.
Hashimoto MCE, Prates RA, Kato IT, Núñez SC, Courrol LC, Ribeiro MS. Antimicrobial photodynamic therapy on drug-resistant Pseudomonas aeruginosa-induced Infection. An In Vivo Study. Photochem Photobiol. 2012;88(3):590–595.
Miyabe M, Junqueira JC, da Costa ACBP, Jorge AOC, Ribeiro MS, Feist IS. Effect of photodynamic therapy on clinical isolates of Staphylococcus spp. Braz Oral Res. 2011;25(3):230–234.
Collins TL, Markus EA, Hassett DJ, Robinson JB. The Effect of a Cationic Porphyrin on Pseudomonas aeruginosa Biofilms. Curr Microbiol. 2010;61(5):411–416. Available from: http://link.springer.com/10.1007/s00284-010-9629-y
Gomes MC, Silva S, Faustino M a. F, Neves MGPMS, Almeida A, Cavaleiro J a. S, et al. Cationic galactoporphyrin photosensitisers against UV-B resistant bacteria: oxidation of lipids and proteins by 1O2. Photochem Photobiol Sci. 2013; (12):262–271.
Banfi S, Caruso E, Buccafurni L, Battini V, Zazzaron S, Barbieri P, et al. Antibacterial activity of tetraaryl-porphyrin photosensitizers: An in vitro study on Gram negative and Gram positive bacteria. J Photochem Photobiol B Biol. 2006;85(1):28–38.
Sabbahi S, Ben Ayed L, Boudabbous A. Cationic, anionic and neutral dyes: effects of photosensitizing properties and experimental conditions on the photodynamic inactivation of pathogenic bacteria. J Water Health. 2013;11(4):590–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24334833
Sun Y, Ogawa R, Xiao BH, Feng YX, Wu Y, Chen LH, et al. Antimicrobial photodynamic therapy in skin wound healing: A systematic review of animal studies. Int Wound J. 2020;17(2):285–299.
Mirzahosseinipour M, Khorsandi K, Hosseinzadeh R, Ghazaeian M, Shahidi FK. Antimicrobial photodynamic and wound healing activity of curcumin encapsulated in silica nanoparticles. Photodiagnosis Photodyn Ther. 2020;29(December 2019):101639. Available from: https://doi.org/10.1016/j.pdpdt.2019.101639
Silva E, Aroso IM, Silva JM, Reis RL. Comparing deep eutectic solvents and cyclodextrin complexes as curcumin vehicles for blue-light antimicrobial photodynamic therapy approaches. Photochem Photobiol Sci. 2022;21(7):1159–1173. Available from: https://doi.org/10.1007/s43630-022-00197-0
Morimoto K, Ozawa T, Awazu K, Ito N, Honda N, Matsumoto S, et al. Photodynamic therapy using systemic administration of 5-aminolevulinic acid and a 410-nm wavelength light-emitting diode for methicillin-resistant Staphylococcus aureus-infected ulcers in mice. PLoS One. 2014;9(8):1–8.
Katayama B, Ozawa T, Morimoto K, Awazu K, Ito N, Honda N, et al. Enhanced sterilization and healing of cutaneous pseudomonas infection using 5-aminolevulinic acid as a photosensitizer with 410-nm LED light. J Dermatol Sci. 2018;90(3):323–331. Available from: https://doi.org/10.1016/j.jdermsci.2018.03.001
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Journal of Human Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors can retain copyright, while granting the journal right of first publication. Alternatively, authors can transfer copyright to the journal, which then permits authors non-commercial use of the work, including the right to place it in an open access archive. In addition, Creative Commons can be consulted for flexible copyright licenses.
©1999 Creative Commons Attribution-ShareAlike 4.0 International License.